N
SYNH

Nuveen’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Nuveen’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-390,106
Closed -$16.4M – 3250
2023
Q2 		$16.4M Sell
390,106
-4,731
-1% -$191K 0.01% 1199
2023
Q1 		$14.1M Sell
394,837
-3,882
-1% -$141K 0.01% 1271
2022
Q4 		$14.6M Sell
398,719
-110,918
-22% -$4.38M 0.01% 1246
2022
Q3 		$24M Buy
509,637
+9,115
+2% +$589K 0.01% 900
2022
Q2 		$35.9M Buy
500,522
+20,232
+4% +$1.48M 0.01% 697
2022
Q1 		$39.4M Sell
480,290
-112,548
-19% -$9.52M 0.01% 748
2021
Q4 		$60.9M Sell
592,838
-46,151
-7% -$4.43M 0.02% 584
2021
Q3 		$55.9M Buy
638,989
+89,213
+16% +$8.08M 0.02% 628
2021
Q2 		$49.2M Buy
549,776
+197,364
+56% +$16.7M 0.01% 746
2021
Q1 		$26.7M Buy
352,412
+13,723
+4% +$1.03M 0.01% 1107
2020
Q4 		$23.1M Sell
338,689
-16,652
-5% -$1.04M 0.01% 1166
2020
Q3 		$18.9M Buy
355,341
+204,873
+136% +$12.2M 0.01% 1097
2020
Q2 		$8.77M Sell
150,468
-323,630
-68% -$17.4M ﹤0.01% 1567
2020
Q1 		$18.7M Sell
474,098
-194,457
-29% -$11.4M 0.01% 943
2019
Q4 		$39.8M Sell
668,555
-23,762
-3% -$1.28M 0.02% 790
2019
Q3 		$36.8M Buy
692,317
+120,837
+21% +$6.2M 0.01% 814
2019
Q2 		$29.2M Buy
+571,480
New +$26.6M 0.01% 952
2017
Q4 		– Sell
-14,193
Closed -$742K – 1164
2017
Q3 		$742K Buy
14,193
+765
+6% +$42.7K ﹤0.01% 833
2017
Q2 		$786K Buy
13,428
+5,548
+70% +$288K 0.01% 811
2017
Q1 		$361K Sell
7,880
-1,959
-20% -$97.5K ﹤0.01% 1237
2016
Q4 		$518K Buy
+9,839
New +$476K ﹤0.01% 1308

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nuveen's SYNH Position: Q3 2023 in Review

Nuveen sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 390,106 shares — an estimated $16.4M sold.

Nuveen first reported a position in SYNH in Q4 2016 and held it in 21 quarters. The position peaked at $60.9M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Nuveen reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Nuveen sold 390,106 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $16.4M.
  • Nuveen first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2016 and held it in 21 quarters.
  • Nuveen's Syneos Health, Inc. Class A Common Stock position peaked at $60.9M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Nuveen's 13F filing for Q3 2023, filed 14 Nov 2023.